Global Microbiome Market

CRISPR Technology Market Definition

The CRISPR technology market consists of sales of CRISPR technology products and related services by entities (organizations, sole traders and partnerships) that produce CRISPR technology products and equipment. CRISPR is a genome-editing tool. It is used by researchers/healthcare professionals to alter DNA sequences and modify gene function. CRISPR is also used for correcting genetic defects, treating human diseases, and to yield better crop varieties. CRISPR stands for Clusters Of Regularly Interspaced Short Palindromic Repeats. The CRISPR-Cas9 system consists of two key molecules, — Cas9 and guide RNA, that introduce a change or mutation into the DNA at the desired position. The Cas9 is an enzyme that acts as a pair of ‘molecular scissors’ and can cut the two strands of DNA at a specific location in the genome so that bits of DNA can then be added or removed. The guide RNA (gRNA is a small piece of pre-designed RNA sequence (about 20 bases long) located within a longer RNA scaffold. The scaffold part binds to DNA and the pre-designed sequence ‘guides’ Cas9 to the right part of the genome. This makes sure that the Cas9 enzyme cuts at the right point in the genome. High orthogonality, versatility, and efficiency of CRISPR technology make it a preferred genome editing technology.

Biobanks Market Definition

The biobanks market consists of sales of biological specimens such as blood products, human tissues, cell lines nucleic acids (DNA, RNA) and other specimens through biorepositories. This market does not include sales generated from the sale of blood to be used for transfusions to treat medical conditions or of statistical information such as age, gender, diet and lifestyles which biobanks collect. A biobank is a collection of human biological specimens including whole organs, tissue, blood products, plasma, urine, or intracellular components such as DNA and RNA. Biobanks are also known as bio-repositories, bio-resources or tissue banks. The primary function of biobanks is to collect, analyze, store and distribute bio-specimens for research purposes and for treating medical conditions. They can be established within academic, medical or research institutions, pharmaceutical/biotechnology companies, hospitals or as stand-alone organizations.

Human Microbiome Therapeutics Market Definition

The human microbiome therapeutics market consists of sales of microbiome and related services used as immunotherapeutic agents in the pharmaceutical industry. Microbiomes are used as immunotherapy for a wide variety of conditions, including infectious diseases, endocrine & metabolic disorders, inflammatory conditions, cancers, irritable bowel syndrome, neurological disorders, hematological disorders and cardiovascular diseases. The microbiome consists of the genetic material within a microbiota, which is the collection of microorganisms, such as bacteria, archaea, fungi, and viruses, in a specific niche, such as the human gut. For example, the gut microbiome consists of collective genome of microbes inhabiting the gut. Microbiomes are also known as the metagenome of the microbiota.

Nanorobotics refers to the discipline of creating and using tiny robots or artificial intelligence (AI)-powered machines to perform tasks. The main goal of future nanorobotics is to infuse multiple robotic functions such as sensing, processing of information, and communication at a scale smaller than the size of a microprocessor or a single cell. The main types of nanorobotics include nano manipulator, electron microscope, transmission electron microscope, scanning probe microscope, bio-nanorobotics, magnetically-guided, and bacteria-based. The nano manipulator refers to a specialized nanorobot and microscopic viewing system for working with objects on a small scale. These systems consist of a large microscope probe that can enlarge an image up to 1 million times the size of the original object operated by self-driven and remote controlled. The nanorobotics is used in nanomedicine, biomedical, mechanical, and other applications. The nanorobotics market research report is one of a series of new reports from The Business Research Company that provides nanorobotics market statistics, including nanorobotics industry global market size, regional shares, competitors with a nanorobotics market share, detailed nanorobotics market segments, market trends and opportunities, and any further data you may need to thrive in the nanorobotics industry. This nanorobotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nanorobotics market size grew from $5.87 billion in 2022 to $6.58 billion in 2023 at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The nanorobotics market size is expected to grow to $9.85 billion in 2027 at a CAGR of 10.6%. The rising incidence of periodontal diseases is expected to propel the growth of the nanorobotics market. Periodontal diseases are the result of infections and inflammation of the gums and bones that will be surrounding and supporting the teeth. The growing interest in the dental applications of nanotechnology has led to the development of a new field called Nano dentistry. Dental nanorobots are being developed to destroy caries-causing or to repair tooth blemishes where decay sets in through computers to direct these tiny robots. For instance, according to the American Cancer Society, a US-based voluntary health organization, in 2022, about 54,000 new cases of the oral cavity or oropharyngeal cancer and about 11, 230 deaths from the oral cavity or oropharyngeal cancer registered in the United States. Therefore, the rising incidence of periodontal diseases is driving the growth of the nanorobotics market. Technological advancement is a key trend gaining popularity in the nanorobotics market. Major companies operating in the nanorobotics market are focused on bringing innovative technological advancements in their nanorobotics solutions and strengthening their position in the market. For instance, In August 2020, JEOL Ltd., a Japan-based developer and manufacturer of electron microscopes and other scientific instruments and launched a new scanning electron microscope (SEM), the JSM-IT700HR, which is equipped with an in-lens Schotty field emission electron gun. This technologically advanced equipment is capable of carrying out observations and analyses of miniature materials in laboratories. In 2020, Nanovery, a UK-based company involved in the development of nanorobots for quick and easy detection of cancer and other diseases entered into strategic partnership with Newcastle University and the Center for Cancer for its research and development activities. Through this partnership, the company is focused on utilizing the human and technological resources of both parties for the development of cutting-edge technologies. Major players in the nanorobotics market are Ginkgo Bioworks, Imina Technologies, Thermo Fisher Scientific, Klocke Nanotechnik, Oxford Instruments, Kliendiek Nanotechnik, Bruker, JEOL, Toronto Nano Instrumentation, EV Group, Nanonics Imaging, Novascan Technologies, Agilent Technologies, Zymergen Inc., Smaract, and Angstrom Advanced. North America was the largest region in the nanorobotics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanorobotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nanorobotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The nanorobotics market includes revenues earned by entities such by providing servies such as arteriosclerosis, tissue engineering, dental surgery, pharmacokinetics monitoring of drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nanorobotics market is segmented - 1) By Type: Nanomanipulator, Electron Microscope, Transmission Electron Microscope, Scanning Probe Microscope, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based 2) By Operation Mode: Self-driven, Remote Controlled 3) By Application: Nanomedicine, Biomedical, Mechanical, Other Applications

Biometrics refers to biological instruments used to identify individuals based on various parameters such as fingerprints, facial recognition, and other attributes that are mainly used for identification and access control and for identifying those who are being monitored based on physical or behavioural characteristics. The main types of biometrics include IRIS recognition, hand geometry, facial recognition, signature verification, fingerprint, voice recognition, and palm vein. IRIS recognition devices refer to devices that capture unique patterns in the coloured circle of the eye to verify and authenticate identity. Biometrics including contact, non-contact and combined devices are used by the government, the military, banking, finance, consumer electronics, healthcare, commercial safety & security, and logistics. The biometrics market research report is one of a series of new reports from The Business Research Company that provides biometrics market statistics, including biometrics industry global market size, regional shares, competitors with a biometrics market share, detailed biometrics market segments, market trends and opportunities, and any further data you may need to thrive in the biometrics industry. This biometrics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global biometrics market size grew from $32.96 billion in 2022 to $39.37 billion in 2023 at a compound annual growth rate (CAGR) of 19.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biometrics market size is expected to grow to $73.5 billion in 2027 at a CAGR of 16.9%. The increasing use of biometric technology in consumer electronics for authentication and identification applications is driving the biometrics market. Biometric sensors are becoming a more common security feature in smartphones and other gadgets, and the low cost of biometric technology allows manufacturers to incorporate them into a larger range of goods. Consumer electronic devices such as access door locks, security devices, home automation, IoT, cars, game consoles, and mobile devices are increasingly utilizing biometric technology to enhance the security of the devices. Fingerprint, face, and voice recognition are becoming more popular methods of authenticating an individual for access and payments. They are faster, simpler, and more secure than standard credentials or PINs, which are difficult to recall and easy to steal. According to a survey conducted by Visa in May 2022, 86% of the consumers are interested in using biometrics to authenticate their identity for making payments, 70% of the consumers responded that biometrics are easier to use, and 46% believe they are more secure than passwords or PINs. Therefore, the increasing use of biometric technology in consumer electronics for authentication and identification applications is expected to boost the biometrics market during the forecast period. Strategic partnership is a key trend gaining popularity in the biometrics market. The companies operating in the biometrics market are focusing on entering into a strategic partnership with technology to expand their product development activities and business reach. In August 2021, NEXT Biometrics, a Norway-based company that delivers high-security fingerprint sensors to device and product manufacturers, entered into a partnership agreement with Paravision to provide dual authentication techniques to clients who require face and fingerprint biometric solutions. Paravision is a US-based computer vision firm that specializes in face recognition. In March 2022, LexisNexis Risk Solutions, a data and analytics company that serves a variety of sectors with data and technology services, acquired BehavioSec for an undisclosed amount. With this acquisition, LexisNexis will integrate BehavioSec's solutions into the risk solution business services, enhancing the company's device and digital identity-focused capabilities, such as LexisNexis ThreatMetrix. BehavioSec is a Sweden-based behavioral biometrics company that uses end users' activities with online and mobile apps to provide continuous authentication. Major players in the biometrics market are Leidos Holdings Inc., NEC Corporation, Fujitsu Limited, Aware Inc., Nuance Communications Inc., IDEMIA, Cognitec Systems, Assa Abloy, BIO-Key International Inc., Thales Group, Stanley Convergent Security Solutions Inc., M2SYS Technology, ImageWare Systems Inc., Accu-Time Systems, IDTECK, Siemens, RCG Holdings Ltd., Suprema Inc., Daon Inc., DERMALOG Identification Systems, and Accenture. North America was the largest region in the biometrics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biometrics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biometrics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biometrics market consists of the sale of speech recognition, finger vein recognition, ear authentication, and retinal scanning. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biometrics market is segmented - 1) By Biometric Type: IRIS Recognition, Hand Geometry, Facial Recognition, Signature Verification, Fingerprint, Voice Recognition, Palm Vein 2) By Functionality: Contact, Non-contact, Combined 3) By End-User: Government, Defense Services, Banking and Finance, Consumer Electronics, Healthcare, Commercial Safety and Security, Transport/Visa/Logistics, Other End Users

A biometric sensor refers to a transducer that turns a biometric trait of an individual into an electrical signal. It tackles a variety of security-related concerns across multiple sectors to identify, verify, and authenticate the identification by using tools such as fingerprints, facial recognition, iris, and voice recognition. The main types of biometric sensors are capacitive sensors, optical sensors, thermal sensors, ultrasound sensors, and electric field sensors. A capacitive sensor is an electronic device that can detect solid or liquid targets without physical contact. The different applications of biometric sensors include voice scans, finger scans, hand scans, facial scans, iris scans, vein scans, and other applications. The end-users for biometric sensors include consumer electronics, commercial centres and buildings, medical research and labs, banks and financial services sectors, defence and security, and other end-users. The biometric sensors market research report is one of a series of new reports from The Business Research Company that provides biometric sensors market statistics, including biometric sensors industry global market size, regional shares, competitors with a biometric sensors market share, detailed biometric sensors market segments, market trends and opportunities, and any further data you may need to thrive in the biometric sensors industry. This biometric sensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global biometric sensor market size grew from $2.67 billion in 2022 to $3.09 billion in 2023 at a compound annual growth rate (CAGR) of 15.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biometric sensor market size is expected to grow to $5.54 billion in 2027 at a CAGR of 15.7%. An increase in the number of identity thefts is expected to propel the growth of the biometric sensor market going forward. Identity theft is the theft of personal information, such as social security numbers, bank account numbers, or credit card numbers. Biometrics meet all of the requirements for authentication, non-repudiation, confidentiality, and integrity, which helps in reducing and eradicating identity theft. For instance, in 2021, according to the Identify Theft Resource Centre, a US-based non-profit organization, the total number of data compromises increased by 68% compared to 2020. Further, according to a report by the Federal Trade Commission (FTC), a US-based consumer protection agency, the number of identity theft cases in the US more than doubled in 2020 from 2019. Therefore, an increase in the number of identity thefts is driving the biometric sensor market. Product innovation is a key trend gaining popularity in the biometric sensor market. Companies in the market are focusing on product innovation and enhanced security measures such as biometric-enabled cards for payments. For instance, in July 2021, Thales Group, a French aerospace company operating in the biometric sensor market, launched the Thales EMV contactless biometric payment card. The contactless biometric card simplifies proximity payments while simultaneously ensuring a high level of privacy and security. A simple and secure personal enrollment method is used to load the user's fingerprint data onto the card, which can be done at home or in a bank branch. The company is amongst the first to offer a contactless biometric card that meets all major payment scheme certification requirements. In April 2020, Fujitsu Frontech North America Inc., a US-based leading provider of innovative technology and IT-based business strategies and applications, acquired Fulcrum Biometrics for an undisclosed amount. With this acquisition, Fujitsu Frontech North America, Inc., intends to improve its biometric authentication solutions business both nationally and globally and also expand its geographical footprint. Fulcrum Biometrics is a US-based provider of advanced biometric hardware and software solutions for fingerprint, face, iris, palm print, palm vein, and voice biometrics. Major players in the biometric sensor market are 3M Company, Crossmatch, Fulcrum Biometrics LLC, NEC Corporation, Precise Biometrics AB, IDEX ASA, Suprema Inc., ZKTeco Inc., SAFRAN S.A., SUPREMA, Mantra Softech (India) Pvt. Ltd., SparkFun Electronics, BioEnable Technologies Pvt. Ltd., NEXT Biometrics Group ASA, Synaptics Incorporated, HID Global Corporation, Integrated Biometrics, and NITGEN CO.LTD. North America was the largest region in the biometric sensor market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the biometric sensor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biometric sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The biometric sensor market consists of sales of signature verification machine, hand geometry, and speech recognition equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biometric sensor market is segmented - 1) By Type: Capacitive Sensors, Optical Sensors, Thermal Sensors, Ultrasound Sensors, Electric Field Sensors 2) By Application: Voice Scan, Finger Scan, Hand Scan, Facial Scan, Iris Scan, Vein Scan, Other Applications 3) By End-User: Consumers Electronics, Commercial Centers And Buildings, Medical Research And Lab, Bank And Finance Service Sector, Defense and Security, Other End-Users

In-vitro diagnostics devices and equipment is a gadget that tests human samples collected from the human body such as tissues and blood, with the goal of using the results to help with clinical diagnosis or management. The main types of in-vitro diagnostics equipment are point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices, and equipment, and immunohematology diagnostic devices, and equipment. Hematology instruments are machines that analyze blood. The hematology instruments perform blood counts, detect proteins or enzymes, and help to diagnose illnesses or genetic defects. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The in-vitro diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics devices and equipment market statistics, including in-vitro diagnostics devices and equipment industry global market size, regional shares, competitors with a in-vitro diagnostics devices and equipment market share, detailed in-vitro diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics devices and equipment industry. This in-vitro diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global in-vitro diagnostics market grew from $95.6 billion in 2022 to $106.53 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The in-vitro diagnostics market is expected to grow to $148.58 billion in 2027 at a CAGR of 8.7%. Demand for point-of-care diagnostic devices is increasing as they provide rapid results, are cost-effective, and have advanced diagnosis features for patients. The number of patients seeking treatments at local physician offices, retail clinics, and in-patient homes is increasing thus boosting the demand for point-of-care testing devices. Companies in this market are focusing on developing more user-friendly, reliable, and efficient point of care devices. For instance, in March 2020, Abbott launched Novel COVID-19 Test. The test will be used on the m2000 RealTime system available in hospitals and molecular labs in the U.S. Philips also launched a new handheld blood test, Handheld Minicare I-20 system used for diagnosing heart attacks in emergency departments which provide results within 10 minutes. IVD devices are being integrated with IoT and data analytics technologies to improve device efficiency and increase device security. IoT refers to a system of interconnected devices via communication technologies such as WIFI and Bluetooth for data transfer and accessing devices remotely. Data analytics refers to qualitative and quantitative techniques, used to infer actionable information from large data sets. These technologies are helping in enhancing IVD device functionality, mainly through remote monitoring, predictive maintenance for decreased downtime, and advanced data processing capabilities. Major companies in the in-vitro diagnostics devices and equipment market include Siemens Healthineers, F. Hoffmann-La Roche Ltd., Danaher (Beckman Coulter Inc), Abbott Laboratories Inc., and Thermo Fisher Scientific Inc. North America was the largest region in the global in-vitro diagnostics market in 2022. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the in-vitro diagnostics devices and equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The in-vitro diagnostics devices and equipment market consist of sales of kits, reagents, piece of software, system, and instrument. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global in-vitro diagnostics market is segmented - 1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

The microbiome therapeutics market consists of sales of microbiome therapeutics and related services by entities (organizations, sole traders, partnership) which are used to treat and prevent various diseases. The microbiome comprises the genetic material within a microbiota which is an entire collection of microorganisms found in and on all multicellular organisms. The main products of microbiome therapeutics are probiotics, prebiotics, symbiotics, and other products. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in the body. The various distribution channels involved are hospital pharmacies, drug stores, retail pharmacies, and e-commerce stores. The applications included are inflammatory bowel disease, diabetes, multiple sclerosis, rheumatoid arthritis, and other applications. The global microbiome therapeutics market size is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%. The global microbiome therapeutics market size is expected to grow to $1 billion in 2026 at a compound annual growth rate (CAGR) of 26.4%. The rising prevalence of obesity is expected to propel the growth of the microbiome therapeutics market. Sedentary lifestyles, busy work lives, and unhealthy food choices are gradually becoming the leading causes of obesity globally. Growing urbanization and busy lifestyles are leading to an increasing preference for packaged and processed foods and physical inactivity. Microbiome therapeutics help prevent and treat diabetes by regulating sugar levels. For instance, in 2022, according to the UK Parliament, a survey found that men are more likely than women to be overweight or obese (68.2% of men, 60.4% of women). People aged 45–74 are most likely to be overweight or obese. Therefore, the rising prevalence of obesity is driving the growth of microbiome therapeutics. Increased research and development is a key trend gaining popularity in the microbiome therapeutics market. Companies operating in the microbiome therapeutics market are focused on developing new innovations to increase their market share. For instance, in March 2022, Microbiotica, a UK-based company, raised $67 million in a Series B round to push two microbiome-based lead assets through phase 1b trials, slated to start this year. In April 2022, Xbiome Inc., a China-based artificial intelligence microbiome therapeutics startup, acquired a clinical-stage M201 program from Assembly Biosciences, Inc. for an undisclosed amount. This acquisition reflects Xbiome’s commitment as one of the leaders in the rising field of microbiome therapeutics. Assembly Biosciences, Inc. is a US-based clinical-stage biotechnology company. Major players in the microbiome therapeutics market are Seres Therapeutics, Enterome Bioscience, Rebiotix, Microbiome Therapeutics, and Ritter Pharmaceuticals. North America was the largest region in the microbiome therapeutics market in 2021. The regions covered in the global microbiome therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the microbiome therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global microbiome therapeutics market is segmented - 1) By Product: Probiotics, Prebiotics, Symbiotics, and Others 2) By Application: Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Others 3) By Distribution Channel: Hospital Pharmacies, Drug stores, Retail Pharmacies, and E-commerce stores